(Life News)—CatholicVote joined a coalition of pro-life organizations in a letter calling on Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and Food and Drug Administration (FDA) Commissioner Dr. Marty Makary to protect women from the risks associated with the abortion drug mifepristone and reinstate safety restrictions that were loosened under the Biden administration.
“The recent revelation of commercial insurance data from 865,727 prescribed chemical abortions between 2017 and 2023 showing 94,605 women suffered serious adverse events indicates that more than one out of ten women are put at risk by mifepristone,” stated a letter signed by 114 organizations, including CatholicVote. “This real-world rate is twenty-two times greater than the rate claimed by the FDA.”
The letter went on to note the “clear” danger the drug poses to women and girls.
“Nearly 11% of women taking mifepristone experience sepsis, infection, hemorrhage, or another serious adverse event within 45 days of taking the drug,” the coalition pointed out.
Despite those warning signs, the FDA under Democratic Presidents Barack Obama and Joe Biden
- Removed the Risk Evaluation and Mitigation Strategy (REMS) requirements to report these serious consequences
- Removed protections like requiring a provider to meet with a woman in person before prescribing the drug to rule out dangerous conditions like ectopic pregnancies, and
- Removed requirements for the provider to follow up with a woman in person to check on her condition after she ingests mifepristone. It even removed the requirement that a doctor be involved at any stage in the chemical abortion process.
Appealing to the FDA’s stated mission to protect public health by ensuring the safety of drugs and keeping Americans informed about scientific research pertaining to health, the coalition warned that the purpose of the agency has “been undermined by political whims that obscured the growing evidence of mifepristone’s harm.”
- Read More: lifenews.com
